Spark Investment Management LLC Arvinas, Inc. Transaction History

Spark Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$29.88 - $56.74 $445,212 - $845,426	-14,900 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$33.0 - $54.5 $2.37 Million - $3.91 Million	-71,700 Reduced 82.79%	14,900 $600,000
Q4 2019 Feb 11, 2020	BUY	$15.39 - $44.38 $313,956 - $905,352	20,400 Added 30.82%	86,600 $3.56 Million
Q2 2019 Aug 12, 2019	BUY	$15.96 - $23.8 $489,972 - $730,660	30,700 Added 86.48%	66,200 $1.46 Million
Q1 2019 May 07, 2019	BUY	$13.55 - $23.79 $230,350 - $404,430	17,000 Added 91.89%	35,500 $523,000
Q4 2018 Feb 12, 2019	BUY	$11.19 - $18.56 $207,015 - $343,360	18,500 New	18,500 $237,000

224

70.9M

1.52M

346K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $986M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.